We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




WHO Adopts New Safety Needle Policy

By HospiMedica International staff writers
Posted on 11 May 2015
Print article
Image: Examples of the K1 auto-disable smart syringe (Photo courtesy of Star Syringe).
Image: Examples of the K1 auto-disable smart syringe (Photo courtesy of Star Syringe).
The World Health Organization (WHO; Geneva, Switzerland) has launched a new policy to make unsafe injections less prevalent by promoting the use of safety-engineered syringes for intramuscular, intradermal, and subcutaneous injections.

WHO is urging countries to transition by 2020 to the exclusive use of the smart syringes, except in select circumstances, such as syringe programs for people who inject themselves with drugs and medication. As part of that initiative, manufacturers are urged as soon as possible to begin or expand their production of smart syringes. Other key strategies recommended are continued training of health workers on injection safety, and the implementation of policies and standards for the procurement, safe use, and safe disposal of syringes that have the potential for reuse.

Several smart syringe design options exist, including a syringe with a plunger that breaks if the user attempts to pull it back a second time, others that have a clip to block the same movement; some syringes utilize retracting needles that prevent a second use. Syringes are also being designed with features that protect health workers from needle stick injuries, such as a sheath or hood that slides over the needle after the injection is completed, which protect the user from being accidental needle-stick injury, and potentially exposed to an infection.

According to WHO, 16 billion injections are administered annually, with 5% of these injections used for immunization, and another 5% used for procedures such as blood transfusions and injectable contraceptives. The remaining 90% of injections are given in an intramuscular, subcutaneous, or intradermal route for administration of medication. WHO therefore stressed the need to reduce the number of unnecessary injections as a way of reducing risk, since in many cases these injections are unnecessary or could be replaced by oral delivery.

“We know the reasons why this is happening. One reason is that people in many countries expect to receive injections, believing they represent the most effective treatment,” said Edward Kelley, MD, director of the WHO service delivery and safety department. “Another is that for many health workers in developing countries, giving injections in private practice supplements salaries that may be inadequate to support their families.”

A 2014 study sponsored by WHO estimated that in 2010 unsafe injections resulted in up to 1.7 million people infected with Hepatitis B virus, up to 315,000 with Hepatitis C virus, and as many as 33,800 with HIV. WHO also cited several cases in which an unsafe injection protocol has led to the unnecessary outbreak of infectious disease. In 2007, a doctor in Nevada (USA) reused hepatitis C-contaminated syringes. In Cambodia, more than 200 children and adults tested positive for HIV, in an outbreak that is thought to have occurred due to unsafe injections.

Related Links:

World Health Organization


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.